|
| Entrez Id: |
2886 |
| Gene Symbol: |
GRB7 |
GRB7
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated molecular analysis of clear-cell renal cell carcinoma.
|
23797736 |
2013 |
|
| Entrez Id: |
8314 |
| Gene Symbol: |
BAP1 |
BAP1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated molecular analysis of clear-cell renal cell carcinoma.
|
23797736 |
2013 |
|
| Entrez Id: |
55745 |
| Gene Symbol: |
AP5M1 |
AP5M1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated molecular analysis of clear-cell renal cell carcinoma.
|
23797736 |
2013 |
|
| Entrez Id: |
7157 |
| Gene Symbol: |
TP53 |
TP53
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated molecular analysis of clear-cell renal cell carcinoma.
|
23797736 |
2013 |
|
| Entrez Id: |
81562 |
| Gene Symbol: |
LMAN2L |
LMAN2L
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated molecular analysis of clear-cell renal cell carcinoma.
|
23797736 |
2013 |
|
| Entrez Id: |
3778 |
| Gene Symbol: |
KCNMA1 |
KCNMA1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated molecular analysis of clear-cell renal cell carcinoma.
|
23797736 |
2013 |
|
| Entrez Id: |
8314 |
| Gene Symbol: |
BAP1 |
BAP1
|
0.300 |
Biomarker
|
disease |
CTD_human |
BAP1 loss defines a new class of renal cell carcinoma.
|
22683710 |
2012 |
|
| Entrez Id: |
3566 |
| Gene Symbol: |
IL4R |
IL4R
|
0.300 |
Biomarker
|
disease |
CTD_human |
Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma.
|
22317767 |
2012 |
|
| Entrez Id: |
3596 |
| Gene Symbol: |
IL13 |
IL13
|
0.300 |
Biomarker
|
disease |
CTD_human |
Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma.
|
22317767 |
2012 |
|
| Entrez Id: |
238 |
| Gene Symbol: |
ALK |
ALK
|
0.300 |
Biomarker
|
disease |
CTD_human |
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.
|
22743654 |
2012 |
|
| Entrez Id: |
79026 |
| Gene Symbol: |
AHNAK |
AHNAK
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
23224 |
| Gene Symbol: |
SYNE2 |
SYNE2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
9820 |
| Gene Symbol: |
CUL7 |
CUL7
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
8314 |
| Gene Symbol: |
BAP1 |
BAP1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
91752 |
| Gene Symbol: |
ZNF804A |
ZNF804A
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
2034 |
| Gene Symbol: |
EPAS1 |
EPAS1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.
|
21131975 |
2011 |
|
| Entrez Id: |
4286 |
| Gene Symbol: |
MITF |
MITF
|
0.300 |
Biomarker
|
disease |
CTD_human |
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
|
22012259 |
2011 |
|
| Entrez Id: |
8242 |
| Gene Symbol: |
KDM5C |
KDM5C
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
84433 |
| Gene Symbol: |
CARD11 |
CARD11
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
57731 |
| Gene Symbol: |
SPTBN4 |
SPTBN4
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
6261 |
| Gene Symbol: |
RYR1 |
RYR1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
210 |
| Gene Symbol: |
ALAD |
ALAD
|
0.300 |
Biomarker
|
disease |
CTD_human |
Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.
|
21799727 |
2011 |
|
| Entrez Id: |
374393 |
| Gene Symbol: |
FAM111B |
FAM111B
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
7248 |
| Gene Symbol: |
TSC1 |
TSC1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
|
| Entrez Id: |
53353 |
| Gene Symbol: |
LRP1B |
LRP1B
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |